一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Annals of Pharmacotherapy >>article
Annals of Pharmacotherapy

Annals of Pharmacotherapy

IF: 2.29
Download PDF

Isavuconazole: A New Option for the Management of Invasive Fungal Infections.

Published:1 July 2015 DOI: 10.1177/1060028015581679 PMID: 25940222
Natasha N Pettit, Peggy L Carver

Abstract

Objective: To review the pharmacology, chemistry, in vitro susceptibility, pharmacokinetics, clinical efficacy, safety, tolerability, dosage, and administration of isavuconazole, a triazole antifungal agent.

Data sources: Studies and reviews were identified through an English language MEDLINE search (1978 to March 2015) and from http://www.clinicaltrials.gov, Food and Drug Administration (FDA) briefing documents, program abstracts from international symposia, and the manufacturer's Web site.

Study selection and data extraction: All published and unpublished trials, abstracts, in vitro and preclinical studies, and FDA briefing documents were reviewed.

Data synthesis: Isavuconazole has activity against a number of clinically important yeasts and molds, including Candida spp, Aspergillus spp, Cryptococcus neoformans, and Trichosporon spp and variable activity against the Mucorales. Isavuconazole, available for both oral and intravenous administration, is characterized by slow elimination allowing once-daily dosing, extensive tissue distribution, and high (>99%) protein binding. The most commonly reported adverse events, which are mild and limited in nature, include nausea, diarrhea, and elevated liver function tests. Its drug interaction potential appears to be similar to other azole antifungals but less than those observed with voriconazole. Comparative trials are under way or have been recently completed for the treatment of candidemia, invasive candidiasis and aspergillosis, and rare mold infections.

Conclusions: Isavuconazole has a broad spectrum of activity and favorable pharmacokinetic properties, providing an advantage over other currently available broad-spectrum azole antifungals and a clinically useful alternative to voriconazole for the treatment of invasive aspergillosis. It may also prove useful for the treatment of candidemia and invasive mold infections; however, these indications await the results of clinical trials.

Substances (6)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Voriconazole 137234-62-9 C16H14F3N5O 749 suppliers $9.00-$2744.01
Isavuconazole 241479-67-4 C22H17F2N5OS 375 suppliers $8.00-$1800.00
CRYPTOCOCCUSNEOFORMANS 16 suppliers Inquiry
CANDIDASPP 8 suppliers Inquiry
ASPERGILLUSSPP 6 suppliers Inquiry
Proteus spp antibody 3 suppliers Inquiry

Similar articles

IF:2.8

Role of isavuconazole in the treatment of invasive fungal infections.

Therapeutics and Clinical Risk Management Dustin T Wilson, V Paul Dimondi,etc Published: 3 August 2016
IF:13

Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis

Drugs M. Shirley,?L. Scott,etc Published: 20 October 2016
IF:3.5

Clascoterone: a new topical anti-androgen for acne management

International Journal of Dermatology Parvathy Santhosh MD, Mamatha George MD,etc Published: 9 July 2021
福州市| 云浮市| 玉山县| 利辛县| 福海县| 攀枝花市| 同心县| 塔城市| 邵阳县| 永嘉县| 特克斯县| 濮阳市| 河池市| 鸡泽县| 噶尔县| 苏尼特右旗| 勐海县| 秦安县| 阿克苏市| 泊头市| 巩义市| 鄯善县| 江华| 大化| 平乐县| 黑水县| 皋兰县| 泽州县| 渭南市| 玉龙| 合川市| 阿拉善左旗| 赤城县| 云和县| 甘南县| 江孜县| 江川县| 德安县| 海原县| 天祝| 林甸县|